ArticleJournal of human immunity2026

STAT2 R148 variant: A 16th-century founder mutation and clinical response to high-dose JAK inhibitor therapy.

Nima Parvaneh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.